Chromocure Inc (KKUR)

[Frankiebones]

Due to recent significant developments within the mainstream scientific community, the company will soon announce new business development and marketing programs.  The Company’s technology is designed around the chromosomal theory of cancer.  The Company has long known the validity of this cancer theory and welcomes new research published by the world-recognized Mayo Clinic.   As shareholders will recall from recent announcements, the Mayo Clinic recently proved the chromosomal basis of cancer.  Their research confirms the chromosomal theory of cancer and immediately establishes the company’s technology in the forefront of both cancer detection and research.  ChromoCure's proprietary CS200 Chromosomal Scanner system and related technology is specifically designed to target the unique chromosomal characteristics demonstrated in the Mayo Clinic research.   Detecting the unique chromosomal signature of cancer yields an effectively 100% accurate method of detecting all forms of cancer at all stages.